Image For Activity Cover
Exploring HCM Diagnosis and Treatment Options: The New Frontier of Cardiac Myosin Inhibitors
Exploring HCM Diagnosis and Treatment Options: The New Frontier of Cardiac Myosin Inhibitors

This activity was planned with the overall goal of improving diagnostic accuracy, overcoming challenges in management, addressing disparities in care, and optimizing patient outcomes. 

Accreditation Statement 

In accordance with ACCME policy, prior to participating in this activity, you must review the information on this page. 

Joint Accreditation 
A logo for a companyDescription automatically generated 
In support of improving patient care, the American College of Cardiology Foundation (ACCF) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.


Credit Statement 


The ACCF designates this online enduring material for a maximum of up to 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


The ACCF designates this educational activity for a maximum of 1.5 continuing nursing education contact hours. Nurses should only claim credit commensurate with the extent of their participation in the activity.

Successful completion of this JACC Journal CME/MOC activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 Medical Knowledge MOC point in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program.

Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.


A logo for a companyDescription automatically generated

This activity was planned by and for the healthcare team, and learners will receive 1.5 Interprofessional Continuing Education (IPCE) credits for learning and change.



Target Audience: 

The primary target audience is general cardiologists as well as hypertension specialists, and advanced practice providers including nurse practitioners, physician assistants and pharmacists.

Important Dates: 
Date of Release:
 June 7, 2024
Term of Approval/Date of Expiration: April 7, 2025
Learner Objectives:  
Upon completion, learners should be able to:  

  1. Identify innovative diagnostic approaches to differentiate HCM, providing insights into future directions in the field.  
  2. Create treatment plans with innovative approaches while considering evolving guidelines for HCM management.  
  3. Describe the role of the Cardiac care team in providing diagnosis and treatment for HCM, considering holistic patient care.  
  4. Develop strategies to mitigate disparities, ensuring equitable access to specialized HCM care and interventions across diverse patient populations.  

Educational grant support provided by 
Bristol Myers Squibb.


Anjali Owens, MD 
Matthew Martinez, MD, FACC 
Purvi Parwani, MD, FACC 

Robyn Bryde, MD 


Availability: On-Demand
Expires on Apr 06, 2025
Cost: FREE
Credit Offered:
1.5 CME Credits
1.5 CNE Credits
1.5 ABIM-MOC Points
1.5 IPCE Credits
Android App Download IOS App Download Powered By